Immunocore Holdings plc Files Definitive Proxy Statement
Ticker: IMCR · Form: DEF 14A · Filed: Apr 4, 2025 · CIK: 1671927
| Field | Detail |
|---|---|
| Company | Immunocore Holdings PLC (IMCR) |
| Form Type | DEF 14A |
| Filed Date | Apr 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
Immunocore proxy filed. Vote on directors & pay. May 15 meeting.
AI Summary
Immunocore Holdings plc filed its definitive proxy statement on April 4, 2025, for its annual meeting on May 15, 2025. The filing outlines the company's governance and proposals for shareholder votes, including the election of directors and approval of executive compensation. Specific details on executive compensation packages and any proposed amendments to equity incentive plans are expected to be detailed within the full proxy statement.
Why It Matters
This filing is crucial for shareholders as it details the company's leadership, executive pay, and key decisions to be voted on, impacting the company's strategic direction and shareholder value.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that provides information to shareholders and does not inherently introduce new risks.
Key Numbers
- 20250404 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
- 20250515 — Meeting Date (Date of the shareholder meeting for which the proxy statement is issued.)
Key Players & Entities
- Immunocore Holdings plc (company) — Registrant
- 0001140361-25-012123 (filing_id) — Accession Number
- 20250404 (date) — Filing Date
- 20250515 (date) — Meeting Date
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information regarding the company's annual meeting, including proposals to be voted on, such as the election of directors and executive compensation.
When was this definitive proxy statement filed?
This definitive proxy statement was filed on April 4, 2025.
When is the shareholder meeting scheduled?
The shareholder meeting is scheduled for May 15, 2025.
What is the company's name and ticker symbol?
The company's name is Immunocore Holdings plc. A ticker symbol is not provided in this excerpt.
What is the SIC code for Immunocore Holdings plc?
The Standard Industrial Classification (SIC) code for Immunocore Holdings plc is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 4, 2025 regarding Immunocore Holdings plc (IMCR).